>Brookings Oregon News, Sports, & Weather | The Curry Coastal Pilot

News Classifieds Web
web powered by Web Search Powered by Google

News arrow News arrow Business arrow SHINN AWARDED CREDENTIAL

SHINN AWARDED CREDENTIAL Print E-mail
July 11, 2000 11:00 pm

Bobbi Shinn, coordinator of the Hanscam Center One-Stop, was recently awarded the Certified Workforce Development Professional credential by the National Association of Workforce Development Professionals.

Bobbi Shinn, the Hanscam Center One-Stop coordinator, exemplifies the degree of professionalism and commitment to excellence that America needs if it is to continue to enjoy a world-class workforce, said Ed McCann, association president.

Workforce development professionals facilitate the process by which individuals prepare for, obtain and maintain employment and self-sufficiency, officials said.

The credential recognizes the training, experience and expertise of professionals in the field in 12 areas of competency including career development process, customer service, job search skills and program management, officials said.

I was really excited because Im only No. 352 in the U.S. Im the only one I know of in Curry County, said Shinn. It took a long time to get and Im happy about it.

Shinn was presented with the credential at the National Association of Workforce Development Professionals in Reno, Nev.

The Certified Workforce Development Professional program is administered and endorsed by the National Association of Workforce Development Professionals.

The associations mission is to be the national voice of the profession and to meet the individual professional development needs of its membership, officials said.

 

Business News by Yahoo Finance

  • GM to battle VW in China with $12 billion investment and new plants
    U.S. car giant General Motors Corp (GM) (GM) plans to invest $12 billion in China from 2014 to 2017 and build more plants next year as it competes with aggressive rivals in the world's largest auto market. GM expects its China sales to expand 8-10 percent this year, in line with the overall growth of the Chinese market, where foreign firms, such as Volkswagen AG (VOW3.DE), and domestic players like SAIC Motor Corp vie for more market share. In total we are investing $12 billion between 2014 and 2017," Matt Tsien, president of GM China, said at the Auto China show in Beijing. GM plans to build five more plants in China next year, as part of its efforts to ramp up manufacturing capacity there by 65 percent by 2020, executives said on Sunday.
  • Pipeline delay gives boost to Obama's political base
    The latest delay to a final decision on the Keystone XL oil pipeline will reinforce a White House strategy to energize President Barack Obama's liberal-leaning base before fall elections in which Democrats risk losing control of the U.S. Senate. Environmentalists, worried about the project's effect on climate change, have put enormous pressure on the president to reject the pipeline from Canada's oil sands, staging demonstrations outside the White House and protests in states where he travels. A decision to approve it now could have prompted that vocal group, which was instrumental in electing Obama in 2008 and 2012, to sit out the November 4 congressional elections. The State Department's announcement on Friday that it would give government agencies more time to study the project was seen by strategists from both parties as a move to prevent that and boost Obama in the eyes of his supporters.
  • Pfizer considers $100 billion bid for AstraZeneca: report
    U.S. pharmaceutical giant Pfizer (PFE) has approached British rival AstraZeneca (AZN.L) to propose a 60 billion pound ($101 billion) takeover, Britain's Sunday Times reported. The paper cited senior investment bankers and industry sources saying that informal conversations about a deal had taken place between the two but that no talks were currently under way after AstraZeneca resisted the approach. Pfizer and AstraZeneca both declined to comment on the report to Reuters. AstraZeneca, Britain's second-biggest pharmaceuticals group, has been frequently touted as a potential takeover target as it wrestles with patents expiring on a number of best-selling drugs, leaving future growth uncertain.

Follow Curry Coastal Pilot headlines on Follow Curry Coastal Pilot headlines on Twitter

© Copyright 2001 - 2014 Western Communications, Inc. All rights reserved. By Using this site you agree to our Terms of Use